RU2001126525A - The use of xenon for the treatment of neurointoxications - Google Patents
The use of xenon for the treatment of neurointoxicationsInfo
- Publication number
- RU2001126525A RU2001126525A RU2001126525/14A RU2001126525A RU2001126525A RU 2001126525 A RU2001126525 A RU 2001126525A RU 2001126525/14 A RU2001126525/14 A RU 2001126525/14A RU 2001126525 A RU2001126525 A RU 2001126525A RU 2001126525 A RU2001126525 A RU 2001126525A
- Authority
- RU
- Russia
- Prior art keywords
- xenon
- use according
- neurointoxication
- composition
- caused
- Prior art date
Links
- 229910052724 xenon Inorganic materials 0.000 title claims 14
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon(0) Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 title claims 14
- 239000000203 mixture Substances 0.000 claims 8
- 239000001301 oxygen Substances 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 5
- 239000007789 gas Substances 0.000 claims 3
- 239000008246 gaseous mixture Substances 0.000 claims 3
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 230000001225 therapeutic Effects 0.000 claims 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 claims 1
- 206010008190 Cerebrovascular accident Diseases 0.000 claims 1
- 206010070976 Craniocerebral injury Diseases 0.000 claims 1
- 206010011878 Deafness Diseases 0.000 claims 1
- 206010013654 Drug abuse Diseases 0.000 claims 1
- 208000004559 Hearing Loss Diseases 0.000 claims 1
- 206010011879 Hearing loss Diseases 0.000 claims 1
- SFLSHLFXELFNJZ-MRVPVSSYSA-N L-Noradrenaline Natural products NC[C@@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-MRVPVSSYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- 206010027599 Migraine Diseases 0.000 claims 1
- 208000008085 Migraine Disorders Diseases 0.000 claims 1
- 229960002748 Norepinephrine Drugs 0.000 claims 1
- 206010061536 Parkinson's disease Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000005765 Traumatic Brain Injury Diseases 0.000 claims 1
- 230000002612 cardiopulmonary Effects 0.000 claims 1
- 229960003638 dopamine Drugs 0.000 claims 1
- 231100000888 hearing loss Toxicity 0.000 claims 1
- 239000002858 neurotransmitter agent Substances 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
Claims (19)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19910986.9 | 1999-03-11 | ||
DE19910986A DE19910986C2 (en) | 1999-03-11 | 1999-03-11 | Use of xenon in the treatment of neurointoxication |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001126525A true RU2001126525A (en) | 2003-06-27 |
RU2246949C2 RU2246949C2 (en) | 2005-02-27 |
Family
ID=7900688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001126525/14A RU2246949C2 (en) | 1999-03-11 | 2000-03-08 | Method for applying xenon for treating neurointoxication |
Country Status (29)
Country | Link |
---|---|
US (3) | US6559190B1 (en) |
EP (1) | EP1158992B2 (en) |
JP (1) | JP4954373B2 (en) |
KR (1) | KR100674407B1 (en) |
CN (1) | CN1170544C (en) |
AR (1) | AR022886A1 (en) |
AT (1) | ATE248599T1 (en) |
AU (1) | AU757361B2 (en) |
BG (1) | BG105889A (en) |
BR (1) | BR0010456A (en) |
CA (1) | CA2367136C (en) |
CZ (1) | CZ302864B6 (en) |
DE (2) | DE19910986C2 (en) |
DK (1) | DK1158992T3 (en) |
EE (1) | EE200100480A (en) |
ES (1) | ES2206202T5 (en) |
HK (1) | HK1048073B (en) |
HU (1) | HUP0201393A3 (en) |
IL (2) | IL145177A0 (en) |
MD (1) | MD2935C2 (en) |
NO (1) | NO20014379L (en) |
PL (1) | PL202941B1 (en) |
PT (1) | PT1158992E (en) |
RS (1) | RS49756B (en) |
RU (1) | RU2246949C2 (en) |
SI (1) | SI1158992T1 (en) |
SK (1) | SK285111B6 (en) |
WO (1) | WO2000053192A1 (en) |
ZA (1) | ZA200107291B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011081612A1 (en) * | 2009-12-31 | 2011-07-07 | Bondarenko Vitaliy Leonidovich | Use of krypton or xenon as an antiviral agent |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9913677D0 (en) | 1999-06-11 | 1999-08-11 | Imperial College | Formulation |
GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
US6653354B2 (en) | 1999-07-29 | 2003-11-25 | Protexeon Limited | NMDA antagonist comprising xenon |
DE10045829A1 (en) * | 2000-09-14 | 2002-04-04 | Messer Griesheim Gmbh | Volatile anesthetic with xenon |
DE10054563A1 (en) * | 2000-11-03 | 2002-05-16 | Messer Griesheim Gmbh | Method and device for making concrete |
WO2002045583A1 (en) * | 2000-12-07 | 2002-06-13 | Mclean Hospital Corporation | Use of magnetic resonance imaging in diagnosis of membrane fluidity-related disorders |
GB0210021D0 (en) | 2002-05-01 | 2002-06-12 | Air Prod & Chem | Ultrasonic gas analyser |
GB0209998D0 (en) * | 2002-05-01 | 2002-06-12 | Protexeon Ltd | Use |
JP2005533062A (en) * | 2002-06-12 | 2005-11-04 | メツサー グリースハイム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | Brain protection with xenon-containing gas |
AU2003249959A1 (en) * | 2002-07-05 | 2004-01-23 | Messer Griesheim Gmbh | Adjuvant containing xenon |
GB0218153D0 (en) * | 2002-08-05 | 2002-09-11 | Ic Innovations Ltd | An analgesic agent for newborn or retal subjects |
US7337776B2 (en) | 2002-08-20 | 2008-03-04 | Aga Ab | Methods for easing pain and anxiety from atrial or ventricular defibrillation |
US7681572B2 (en) | 2002-08-20 | 2010-03-23 | Aga Ab | Method and devices for administration of therapeutic gases |
FR2858233B1 (en) * | 2003-07-30 | 2008-04-11 | Air Liquide Sante Int | INHALABLE GAS MEDICINE BASED ON XENON AND NITROGEN PROTOXIDE |
EP1670489B1 (en) | 2003-10-10 | 2007-12-12 | Protexeon Limited | Use of xenon with hypothermia for treating neonatal asphyxia |
AU2004283448B2 (en) * | 2003-10-21 | 2009-02-19 | Imperial Innovations Limited | Use of xenon for the prevention of programmed cell death |
FR2863169B1 (en) * | 2003-12-08 | 2006-02-10 | Air Liquide Sante Int | ARGON-BASED INHALABLE GAS MEDICINE FOR THE TREATMENT OF NEURO-INTOXICATIONS |
EP1552840A1 (en) * | 2004-01-07 | 2005-07-13 | Aga Ab | Use of a xenon/carbon monoxide mixture for the protection of cells |
US7070005B2 (en) * | 2004-02-10 | 2006-07-04 | Planetair Turf Products, Llc | Soil aerator assembly |
ATE553757T1 (en) * | 2004-08-02 | 2012-05-15 | John W Olney | PREVENTION OF PATHOLOGICAL INCREASE IN NERVOUS CELL SUICIDE RATES IN IMMATURE NERVOUS SYSTEMS |
WO2007075100A1 (en) * | 2005-12-27 | 2007-07-05 | Zakrytoe Aktsionernoe Obshchestvo 'atom-Med Center' | Method for treating drug dependence |
EP1980260A1 (en) * | 2007-04-10 | 2008-10-15 | Nicholas Peter Franks | Use of hyperbaric conditions to provide neuroprotection |
US8435569B2 (en) | 2007-04-30 | 2013-05-07 | Nnoxe Pharmaceutiques Inc. | Pharmaceutical composition comprising at least one thrombolytic agent (A) and at least one gas (B) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon |
ITMI20071031A1 (en) * | 2007-05-22 | 2008-11-23 | Acetilene & Deriv Ati Siad Spa | USE OF XENON FOR THE PROTECTION OF DAMAGED DAMAGE ORGANS |
WO2010035074A1 (en) * | 2008-09-25 | 2010-04-01 | Nnoxe Pharmaceutiques Inc | Use of nitrous oxide, argon, xenon, helium, or neon, for the manufacture of a pharmaceutical composition for treating ischemic insults in patients who cannot be treated with thrombolytic agents |
FR2952305B1 (en) * | 2009-11-10 | 2012-04-27 | Air Liquide | XENON-BASED INHALABLE MEDICINE FOR TREATING OR PREVENTING DYSKINESIES |
FR2956323B1 (en) | 2010-02-15 | 2013-12-20 | Air Liquide | ARGON-BASED INHALABLE GAS MEDICINE AGAINST PERIPHERAL ORGAN DEFECTS OR MALFUNCTIONS |
FR2960779A1 (en) | 2010-06-08 | 2011-12-09 | Air Liquide | INHALABLE GASEOUS MEDICINE BASED ON KRYPTON AGAINST PERIPHERAL ORGAN DEFECTS OR FAILURES |
FR2964036B1 (en) | 2010-08-24 | 2013-04-12 | Air Liquide | INHALABLE GASEOUS MEDICINE BASED ON KRYPTON FOR THE TREATMENT OF NEURO-INTOXICATIONS |
WO2012109107A1 (en) | 2011-02-07 | 2012-08-16 | Rich Products Corporation | Method for preserving cells and cell cultures |
FR2975597B1 (en) * | 2011-05-24 | 2013-12-27 | Air Liquide | USE OF NEON FOR THE TREATMENT OF NEURO-INTOXICATIONS, IN PARTICULAR ENURODEGENERATIVE AND DEMYELINISANT DISEASES |
AR088166A1 (en) | 2011-09-26 | 2014-05-14 | Rich Products Corp | METHOD FOR THE PRESERVATION OF LIVE FABRIC |
RU2489154C1 (en) * | 2012-05-31 | 2013-08-10 | Сергей Александрович Наумов | Method of treating viral hepatites |
CN110464709A (en) | 2012-08-10 | 2019-11-19 | 德克萨斯州大学系统董事会 | For treating the neuroprotective liposome composition and method of apoplexy |
FR2996459B1 (en) * | 2012-10-09 | 2015-02-06 | Air Liquide | USE OF AN ARGON / XENON MIXTURE TO PREVENT OR TREAT THE NEUROLOGICAL CONSEQUENCES OF A SEPTIC SHOCK |
FR2996458B1 (en) | 2012-10-09 | 2015-02-27 | Air Liquide | USE OF XENON TO PREVENT OR TREAT THE NEUROLOGICAL CONSEQUENCES OF A SEPTIC SHOCK |
FR2996457B1 (en) | 2012-10-09 | 2019-11-29 | L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | USE OF ARGON TO PREVENT OR TREAT THE NEUROLOGICAL CONSEQUENCES OF A SEPTIC SHOCK |
WO2014093277A1 (en) | 2012-12-11 | 2014-06-19 | The Mclean Hospital Corporation | Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders |
EP2968126B1 (en) | 2013-03-15 | 2022-04-06 | The Board of Regents of The University of Texas System | Liquids rich in noble gas and methods of their preparation and use |
FR3007983B1 (en) * | 2013-07-08 | 2015-06-26 | Air Liquide | ASSOCIATION OF XENON AND AN NMDA RECEPTOR ANTAGONIST TO FIGHT NEURODEGENERATIVE DISEASE |
FR3022456B1 (en) * | 2014-06-20 | 2016-07-15 | Air Liquide | XENON ASSOCIATED WITH ANTAGONIST OF NMDA RECEPTORS TO FIGHT TUMOR PROLIFERATION IN THE CENTRAL NERVOUS SYSTEM |
FR3027226B1 (en) * | 2014-10-17 | 2017-12-08 | L'air Liquide Sa Pour L'etude Et L'exploitation Des Procedes Georges Claude | MEDICAMENT FOR TREATING A DISEASE RELATED TO A DYSFUNCTION OF THE DOPAMINERGIC SYNAPTIC TRANSMISSION |
AU2016281656B2 (en) * | 2015-06-23 | 2019-05-30 | Nobilis Therapeutics, Inc. | Therapeutic immune modulation using noble gas compositions |
EP3373940A4 (en) * | 2015-11-09 | 2019-10-02 | The McLean Hospital Corporation | Methods and compositions for the prevention of suicide, homicide and self-harming behaviors |
US20170341980A1 (en) * | 2016-05-31 | 2017-11-30 | Noblis Therapeutics, Inc. | Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity |
US10485825B2 (en) * | 2016-08-29 | 2019-11-26 | Nobilis Therapeutics, Inc. | Prevention of pregnancy complications by noble gas administration |
US20200054671A1 (en) * | 2016-10-31 | 2020-02-20 | Nobilis Therapeutics, Inc. | Treatment of anxiety disorder and augmentation of anti-anxiety interventions by administration of noble gas containing mixtures |
CN107569509B (en) * | 2017-02-22 | 2018-09-21 | 滨州医学院 | The purposes of xenon or xenon-133 gas mixture in the preparation for preparing treatment epilepsy |
CN108986622A (en) * | 2018-08-16 | 2018-12-11 | 广州迈普再生医学科技股份有限公司 | A kind of intracranial hematoma microtrauma puncture removes art training device and preparation method thereof |
RU2712804C1 (en) * | 2018-08-29 | 2020-01-31 | Жовнерчук Инна Юрьевна | Method for correction of human functional state in confined space |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5099834A (en) * | 1991-07-16 | 1992-03-31 | Union Carbide Industrial Gases Technology Corporation | Method for anesthesia |
US5228434A (en) * | 1991-07-16 | 1993-07-20 | Praxair Technology, Inc. | Mixture for anesthesia |
US5357959A (en) * | 1993-04-16 | 1994-10-25 | Praxair Technology, Inc. | Altered dipole moment magnetic resonance imaging method |
US5846556A (en) * | 1996-06-14 | 1998-12-08 | Brooks; Bradley S. | Inhalant for reducing stress and method of use |
IT1286058B1 (en) * | 1996-10-29 | 1998-07-07 | Siad Societa Italiana Acetilen | PROCEDURE AND EQUIPMENT FOR THE PURIFICATION AND RECOVERY OF XENON AND OTHER NOBLE GASES IN ANESTHETICS SYSTEMS |
DE19709704C2 (en) * | 1997-03-10 | 1999-11-04 | Michael Georgieff | Use of a liquid preparation of xenon for intravenous administration when inducing and / or maintaining anesthesia |
DE19823606C2 (en) * | 1998-05-27 | 2002-02-28 | Draeger Medical Ag | Use of perfluorocarbons in a breathing gas mixture as well as the device |
GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
-
1999
- 1999-03-11 DE DE19910986A patent/DE19910986C2/en not_active Expired - Lifetime
-
2000
- 2000-03-08 EP EP00910789A patent/EP1158992B2/en not_active Expired - Lifetime
- 2000-03-08 WO PCT/EP2000/002025 patent/WO2000053192A1/en active IP Right Grant
- 2000-03-08 US US09/936,319 patent/US6559190B1/en not_active Expired - Lifetime
- 2000-03-08 MD MDA20010349A patent/MD2935C2/en not_active IP Right Cessation
- 2000-03-08 IL IL14517700A patent/IL145177A0/en active IP Right Grant
- 2000-03-08 RU RU2001126525/14A patent/RU2246949C2/en not_active IP Right Cessation
- 2000-03-08 PL PL350618A patent/PL202941B1/en unknown
- 2000-03-08 HU HU0201393A patent/HUP0201393A3/en unknown
- 2000-03-08 PT PT00910789T patent/PT1158992E/en unknown
- 2000-03-08 ES ES00910789T patent/ES2206202T5/en not_active Expired - Lifetime
- 2000-03-08 SI SI200030258T patent/SI1158992T1/en unknown
- 2000-03-08 BR BR0010456-6A patent/BR0010456A/en not_active Application Discontinuation
- 2000-03-08 DE DE60004974T patent/DE60004974T3/en not_active Expired - Lifetime
- 2000-03-08 EE EEP200100480A patent/EE200100480A/en unknown
- 2000-03-08 AU AU32875/00A patent/AU757361B2/en not_active Ceased
- 2000-03-08 RS YUP-654/01A patent/RS49756B/en unknown
- 2000-03-08 JP JP2000603681A patent/JP4954373B2/en not_active Expired - Fee Related
- 2000-03-08 DK DK00910789T patent/DK1158992T3/en active
- 2000-03-08 KR KR1020017011477A patent/KR100674407B1/en not_active IP Right Cessation
- 2000-03-08 SK SK1279-2001A patent/SK285111B6/en unknown
- 2000-03-08 CN CNB008048924A patent/CN1170544C/en not_active Expired - Lifetime
- 2000-03-08 CZ CZ20013234A patent/CZ302864B6/en not_active IP Right Cessation
- 2000-03-08 CA CA002367136A patent/CA2367136C/en not_active Expired - Fee Related
- 2000-03-08 AT AT00910789T patent/ATE248599T1/en not_active IP Right Cessation
- 2000-03-09 AR ARP000101053A patent/AR022886A1/en not_active Application Discontinuation
-
2001
- 2001-08-29 IL IL145177A patent/IL145177A/en unknown
- 2001-09-03 ZA ZA200107291A patent/ZA200107291B/en unknown
- 2001-09-10 NO NO20014379A patent/NO20014379L/en not_active Application Discontinuation
- 2001-09-11 BG BG105889A patent/BG105889A/en unknown
-
2003
- 2003-01-14 HK HK03100325.3A patent/HK1048073B/en not_active IP Right Cessation
- 2003-01-15 US US10/342,968 patent/US20030180375A1/en not_active Abandoned
-
2007
- 2007-01-04 US US11/650,211 patent/US8143317B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011081612A1 (en) * | 2009-12-31 | 2011-07-07 | Bondarenko Vitaliy Leonidovich | Use of krypton or xenon as an antiviral agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001126525A (en) | The use of xenon for the treatment of neurointoxications | |
JP2002538209A5 (en) | ||
CA2367136A1 (en) | Use of xenon for treating neurointoxications | |
ATE439829T1 (en) | GEL OR SOLUTION CONTAINING DIHYDROTESTOSTERONE, PROCESS OF PRODUCTION AND USE THEREOF | |
PT1263725E (en) | NEW COMPOUNDS | |
JP2004510493A5 (en) | ||
EP1610751A4 (en) | Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use | |
ATE482747T1 (en) | NEW AMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USES | |
IL132156A0 (en) | Neoglycoproteins | |
IL203923A (en) | Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds | |
MX9701292A (en) | Spiro-azabicyclic compounds useful in therapy. | |
DE60219954D1 (en) | New indole-2-one derivatives | |
DE602005016601D1 (en) | 5HT2C RECEPTOR MODULATOR COMPOSITIONS AND APPLICATION METHODS | |
ATE409185T1 (en) | QUINAZOLINE DERIVATIVES | |
CA2436540A1 (en) | Pharmaceutical compositions based on anticholinergics and corticosteroids | |
ATE380016T1 (en) | SPREADING PROCESS FOR PRODUCING POWDER FORMULATIONS | |
CR7271A (en) | NEW MELATONIN-BASED PHARMACEUTICAL FORMULATIONS AND SIMILAR COMPOUNDS FOR USE IN SOUND DISORDERS | |
TR199900087T2 (en) | Alfo-amino acid amides, their preparation and therapeutic uses. | |
RU2000119148A (en) | PHARMACEUTICAL COMPOSITIONS | |
IL168307A (en) | Compositions containing roflumilast and (r,r)-formoterol | |
NO20024673D0 (en) | Controlled-release pharmaceutical composition for oral use containing midodrine and / or desglymidodrine | |
SE9804126D0 (en) | New pharmaceutical composition | |
ATE416162T1 (en) | NAPHTHAMIDE DERIVATIVES AND USE THEREOF | |
DE3671746D1 (en) | SULFINYL- AND SULFONYL-SUBSTITUTED 3-BENZAZEPINE. | |
RU2000116316A (en) | MEANS FOR TREATING BURNS RAS |